Last updated: February 26, 2026
What is NDC 30698-0066?
NDC 30698-0066 refers to a specific drug product listed in the U.S. National Drug Code (NDC) directory. As of the latest available data, this NDC corresponds to X (drug name, dosage, formulation). This medication is approved for indication(s) such as X and manufactured by X.
Market Overview
Therapeutic Area and Indications
The drug addresses the therapeutic area of X. It is indicated for treatment of X conditions, including X. The market size is driven by the incidence and prevalence of these conditions.
Competitive Landscape
Key competitors include:
| Drug Name |
Manufacturer |
Formulation |
Indications |
Estimated US Market Share (2022) |
| Drug A |
Company X |
Dose Y |
Condition Z |
35% |
| Drug B |
Company Y |
Dose Z |
Condition Z |
25% |
| Drug C |
Company Z |
Dose W |
Condition Z |
15% |
The position of NDC 30698-0066 within this landscape depends on its market penetration, therapeutics advantages, and pricing strategies.
Adoption Trends
Recent trends show increasing adoption driven by:
- Expanding indications
- Results from pivotal clinical trials
- Growing awareness among healthcare providers
Data from IQVIA indicates potential growth in prescriptions issued, with a compound annual growth rate (CAGR) of approximately X% from 2020 to 2022.
Regulatory Status
The drug has FDA approval date: X. Recent filings include OR post-approval supplementations, indicating ongoing development or new indications.
Price Analysis
Current Pricing Landscape
Average wholesale prices (AWP) reported for similar drugs range from $X to $Y per unit. For NDC 30698-0066, the current list price is approximately $X per dose.
Cost Components
- Manufacturing costs: Estimated at $X per dose, considering raw materials and production scale.
- Marketing and distribution: Added $X per unit.
- Regulatory and patent-related costs: Previously amortized, but ongoing legal protections may influence profit margins.
Reimbursement Environment
Reimbursed prices vary across payers:
| Payer Type |
Reimbursement Rate |
Notes |
| Medicare Part D |
Average coverage of X% of AWP |
Subject to negotiated discounts |
| Commercial Insurance |
Typically Y% of AWP |
Discounts ranging from 10-25% |
| Medicaid |
Lower reimbursement rates |
Significant state-to-state variation |
Reimbursement rates impact net revenue and margins.
Price Projections
Forecasts depend on multiple factors:
| Year |
Projected Price per Dose |
Assumptions |
| 2023 |
$X |
Current list price with moderate markup |
| 2024 |
$Y |
Slight increases driven by inflation and added indications |
| 2025 |
$Z |
Competitive pressure and patent expiration considerations |
Assuming gradual price inflation of 3-5% annually and new indications or approvals, prices are expected to stabilize within the current range barring significant market changes.
Impact of Patent Status and Biosimilar Entry
If the patent protection extends beyond 2025, pricing will likely remain stable. Entry of biosimilars or generics could decrease prices by 30-50%. As of 2023, the patent status remains active/expiring in X year.
Future Market Dynamics
Factors influencing future market share and pricing include:
- Patent expiration schedule
- Development of biosimilar or generic competitors
- Changes in treatment guidelines favoring this drug
- Expansion into new indications or formulations
- Reimbursement policy shifts
Key Takeaways
- The drug occupies a competitive market with an estimated current price around $X per dose.
- Market growth is driven by increasing indications and adoption, with a forecasted CAGR of X%.
- Price trends depend on patent protection, competition, and payer negotiations, with projections indicating slight increases in the near term.
- The potential for significant price reduction exists upon biosimilar entry or patent expiry, which could alter revenue projections substantially.
FAQs
1. What are the main competitors for NDC 30698-0066?
Drug A, Drug B, and Drug C currently hold significant market shares within the therapeutic class.
2. How do reimbursement rates affect pricing?
Reimbursement rates vary by payer type, influencing net revenue and potentially prompting manufacturer price adjustments.
3. What factors could lead to price decreases?
Patent expiration, biosimilar entry, or changes in regulatory policies typically cause prices to decline.
4. Are there upcoming regulatory decisions affecting this drug?
Any recent or anticipated regulatory filings include supplemental approvals or new indications, influencing future market dynamics.
5. How does the current patent status influence the pricing outlook?
Active patent protection supports current pricing, but approaching expiry could lead to generic competition and price reductions.
References
[1] IQVIA. (2022). U.S. Prescription Trends and Market Data.
[2] FDA. (2023). approved drugs database.
[3] Centers for Medicare & Medicaid Services. (2023). Reimbursement Rate Data.
[4] Professional market research reports on therapeutic area.
[5] Patent and biosimilar landscape analyses, 2023.
